[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"hyperphagia\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:hyperphagia":30},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,56],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":19,"enrollmentInfo":20,"targetDuration":4,"studyType":23,"phases":24,"briefSummary":26,"conditions":27,"keywords":34,"overallStatus":43,"whyStopped":4,"lastUpdateSubmitDate":44,"lastUpdatePostDateStruct":45,"startDateStruct":48,"completionDateStruct":50,"leadSponsor":52,"locationsCount":55},"100511439","impact-of-bright-light-therapy-on-prader-willi-syndrome-100511439",false,"NCT05939453","Impact of Bright Light Therapy on Prader-Willi Syndrome","A Randomized, Double-Blind, Controlled Trial of Bright Light Therapy on All-Cause Excessive Daytime Sleepiness in Prader-Willi Syndrome","PWS-LT","Inclusion Criteria:\n\n* Diagnosis of PWS confirmed by genetic testing\n* Score of 12 or above on the Epworth Sleepiness Scale (ESS).\n\nExclusion Criteria:\n\n* Subjects with an eye condition that could be negatively affected by bright light such as patients with a history of retinal damage or patients needing photosensitizing medications\n* A history of previous treatment with LT\n* Patients presenting with active psychosis or mania","ALL","6 Years","88 Years",{"count":21,"type":22},50,"ESTIMATED","INTERVENTIONAL",[25],"NA","This is a placebo controlled clinical trial to assess the utility of light therapy as a sufficient treatment for excessive daytime sleepiness in patients with Prader-Willi Syndrome",[28,29,30,31,32,33],"Prader-Willi Syndrome","Excessive Daytime Sleepiness","Hyperphagia","Body Weight","Mood","Behavior",[35,36,37,38,39,40,41,42],"Light Therapy","Aberrant Behavior Checklist","Clinical Global Impression- Improvement","Fitbit","Actigraphy reports","Epworth Sleepiness Scale","Hyperphagia Questionnaire (HQCT)","Modified Overt Aggression Scale (MOAS)","RECRUITING","2026-05-13",{"date":46,"type":47},"2026-05-15","ACTUAL",{"date":49,"type":47},"2023-10-01",{"date":51,"type":22},"2026-12",{"name":53,"class":54},"Maimonides Medical Center","OTHER",1,{"id":57,"slug":58,"hasResults":11,"nctId":59,"briefTitle":60,"officialTitle":60,"acronym":61,"eligibilityCriteria":62,"healthyVolunteers":11,"sex":17,"minAge":63,"maxAge":64,"enrollmentInfo":65,"targetDuration":4,"studyType":67,"phases":4,"briefSummary":68,"conditions":69,"keywords":73,"overallStatus":77,"whyStopped":4,"lastUpdateSubmitDate":78,"lastUpdatePostDateStruct":79,"startDateStruct":81,"completionDateStruct":83,"leadSponsor":85,"locationsCount":55},"100595329","exploratory-study-of-sensory-profile-and-coping-strategies-in-eating-disorders-100595329","NCT07031037","Exploratory Study of Sensory Profile and Coping Strategies in Eating Disorders","SensoryCop","Inclusion Criteria:\n\n* Gender and Age: Male or female, aged 18 to 65\n* Confirmed diagnosis of anorexia nervosa (F50.01; F50.02), boulimia nervosa (F50.2), hyperphagic episodes (F50.8) or restriction or avoidance of food intake (F50.8) according to DSM-5 criteria\n* Hospitalization or consultation for Eating Disorder at Centre Hospitalier Esquirol\n* Consent: Free, informed, and written consent, signed by the participant and\u002For their legal representative (for participants under protection measures) and the investigator (at the latest on the day of inclusion and before any research-related examination).\n\nExclusion Criteria:\n\n* Psychiatric comorbidity (non-tobacco addiction, characterized depressive episode, bipolar disorder, obsessive-compulsive disorder, schizophrenia and related disorders, neurodevelopmental disorder)\n* History of Eating Disorder other than current disorder\n* Proven sensory or neurological disability\n* Inability to understand questionnaires and information related to the study\n* Persons under psychiatric care in accordance with articles L. 3212-1 and L. 3213-1\n* Pregnant, nursing or parturient women\n* Adults subject to legal protection or unable to express their consent to express their consent\n* Persons not affiliated to a social security scheme or not benefiting from one social security scheme\n* Persons deprived of their liberty by judicial or administrative decision","18 Years","65 Years",{"count":66,"type":22},150,"OBSERVATIONAL","This descriptive study aims primarily to characterize the sensory profile of patients with eating disorders (divided into three diagnostic groups: anorexia nervosa, boulimia nervosa and hyperphagia), controlling for possible autistic traits in this population.\n\nThe study involves measuring characteristics associated with eating disorders (diagnosis, BMI, anxiety), assessing the sensory profile (AASP), and coping strategies in patients with eating disorders who are hospitalised or followed up in consultation.",[70,71,72,30],"Eating Disorders","Anorexia Nervosa","Boulimia Nervosa",[74,75,70,76],"Sensory Profile","Coping Strategies","sensory processing disorder","NOT_YET_RECRUITING","2025-06-12",{"date":80,"type":47},"2025-06-22",{"date":82,"type":22},"2025-07",{"date":84,"type":22},"2028-07",{"name":86,"class":54},"Centre Hospitalier Esquirol"]